Revive Therapeutics Ltd (RVVTF)

[Jack Torrance]

Well, I am long here, but Revive has bungled this phase 3 trial from the start. First they took 6 months to get a few clinical sites going. Then they took 3-4 months to enroll their first 200 patients. Now their still adding clinical sites and are through about 600 patients (I think). At this rate, they may complete the clinical trial by about March 2022. By then there may be a handful of people on planet Earth still infected with Covid. The profits from treating those people with Bucillamine may be enough for a happy meal from Mickey D's.